SBUX is currently in consolidation phase and there is opportunity to trade for the breakout.
Midas is currently on a confirmed uptrend after rebounding from a Double Bottom (a trend reversal chart pattern). Midas is trading inside a Higher High, Higher Low, uptrend channel, and also above 20D, 50D and 200D SMA. However, Midas is over value base on PE ratio and PEG valuation. Midas is good for a bullish short term trade where there is a pull back near uptrend channel support.
Check out definition of PE & PEG valuation here.
Backgound:
Founded in 2000, Midas is today a leading manufacturer of aluminium alloy extrusion products and PE pipes, primarily for the transportation and infrastructure sectors in the PRC. The Group operates three business divisions; namely, Aluminium Alloy, PE Pipe and Agency and Procurement. Midas is the only PRC certified supplier to the world?s largest train manufacturers, ALSTOM SA, Siemens and Changchun Bombardier. The Group’s customers include a number of MNCs and PRC state-owned companies.
| Current P/E Ratio (ttm) | 32.3933 |
|---|---|
| Estimated P/E (12/2012 ) | 46.8163 |
| Earnings Per Share (CNY) (ttm) | 0.0664 |
| Est. EPS (CNY) (12/2012) | 0.0460 |
| Est. PEG Ratio | 4.6353 |
| Market Cap (M SGD) | 511.40 |
| Shares Outstanding (M) | 1,217.62 |
| Enterprise Value (M CNY) (ttm) | 3,288.03 |
| Enterprise Value/EBITDA (ttm) | 12.04 |
| Price/Book (mrq) | 0.8825 |
| Price/Sale (ttm) | 2.8450 |
| Dividend Indicated Gross Yield | 1.79% |
| Next Earnings Announcement | 11/14/2012 |
Asia’s largest health-care operator IHH Healthcare is replacing container carrier Neptune Orient Lines as one of the 30 component stocks in the benchmark Straits Times Index come Sept 24.
The change followed a review announced on Thursday by the Singapore Press Holdings (SPH), Singapore Exchange Limited (SGX) and FTSE Group (FTSE).
Following Thursday’s review, the next five companies ranked highest on the same basis as the STI companies in order of market valueare Hutchison Port Holdings Trust, Keppel Land, Ascendas Real Estate InvestmentTrust, UOL Group and Capitacommercial Trust.
The Company was incorporated in Malaysia on 21 May 2010 as a holding company for Khazanah’s healthcare investments in Parkway, Pantai, IMU Health and Apollo. The Company was converted to a public company on 2 April 2012. On 20 April 2012, the Company changed its name to IHH Healthcare Berhad.
The Company operates an integrated healthcare business and related services and has leading market positions in its home markets of Singapore, Malaysia and Turkey, and it also has healthcare operations and investments in the People’s Republic of China (excluding Hong Kong, Macau and Taiwan) (“PRC”), India, Hong Kong, Vietnam, Macedonia and Brunei. The Company’s integrated healthcare network provides the full spectrum of healthcare services, from primary healthcare clinics, to secondary and tertiary hospitals, to quaternary care and post-operative rehabilitation centres, complemented by a wide range of ancillary services including diagnostic laboratories, imaging centres, ambulatory care, medical education facilities, hospital project management and other related services.
The Company’s core businesses are operated through its key subsidiaries, namely Parkway Pantai Limited, Acibadem Saglik Yatirimlari Holding A.S. and IMU Health Sdn Bhd.
Parkway Pantai Limited is the holding company for the integrated Parkway and Pantai healthcare businesses in Singapore and Malaysia, respectively, and also has investments and operations in the PRC, India, Hong Kong, Vietnam and Brunei. It is one of Asia’s largest private healthcare providers with a network of hospitals, medical centres and clinics, and ancillary healthcare businesses.
Acibadem Saglik Yatirimlari Holding A.S owns Acibadem, an integrated private healthcare and diagnostics provider with an extensive network across Turkey and a leading player in the Turkish private healthcare sector.
IHH Healthcare IPO information.
| Current P/E Ratio (ttm) | 104.9180 |
|---|---|
| Estimated P/E (12/2012 ) | 44.4444 |
| Earnings Per Share (MYR) (ttm) | 0.0305 |
| Est. EPS (MYR) (12/2012) | 0.0720 |
| Est. PEG Ratio | 1.0421 |
| Market Cap (M MYR) | 25,777.43 |
| Shares Outstanding (M) | 8,055.45 |
| Enterprise Value (M MYR) (ttm) | 32,766.49 |
| Enterprise Value/EBITDA (ttm) | – |
| Price/Book (mrq) | 1.5810 |
| Price/Sale (ttm) | 4.9660 |
| Dividend Indicated Gross Yield | -% |
| Next Earnings Announcement | 11/30/2012 |